Hemostatic abnormalities in nephrotic syndrome.
Nephrotic syndrome is often associated with a hypercoagulable state and thrombotic complications. Thrombosis may be due to a number of abnormalities in blood, including AT III deficiency, increased concentrations of fibrinogen, factors V and VIII, and platelet hyperaggregability. The therapeutic approach to thrombosis in nephrotic syndrome is the use of anticoagulants as a preventive measure or an attempt at thrombolysis with streptokinase, urokinase, or stanozolol.
Abdullah
R
R
Department of Veterinary Pathology and Microbiology, Faculty of Veterinary Medicine and Animal Sciences, University Pertanian Malaysia, Serdang, Selangor.
D000818:Animals; D000925:Anticoagulants / Q000627:therapeutic use; D020152:Antithrombin III Deficiency; D001779:Blood Coagulation Factors / Q000502:physiology; D001792:Blood Platelets / Q000502:physiology; D004283:Dog Diseases; D004285:Dogs; D005342:Fibrinolysis; D006487:Hemostasis; D009404:Nephrotic Syndrome / Q000097:blood / Q000150:complications / Q000662:veterinary*; D011486:Protein C / Q000502:physiology; D013927:Thrombosis / Q000188:drug therapy / Q000209:etiology / Q000662:veterinary*
D000925:Anticoagulants; D001779:Blood Coagulation Factors; D011486:Protein C